Admission to Trading

Summary by AI BETAClose X

Oxford Biomedica has applied for admission to trading of 430,825 new ordinary shares of 50 pence each, allotted under its Long Term Incentive Plan and Deferred Bonus Plan, with admission expected to be effective on 19 November 2026; the New Ordinary Shares will rank pari passu with existing shares. The issuance reflects LTIP/DBP awards, has a nominal value of £215,412.50, and may modestly increase the company's share count without representing a cash capital raise.

Disclaimer*

UK 100

Latest directors dealings